Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Chengyi Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8603-3609; OpenAlex author ID A5101756413. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 13)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 3 papers · 2019: 2 papers · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 16

  1. ZMYND8 promotes the Warburg effect and tumorigenesis through c-Myc activation in pancreatic cancer. Co-author DOI 10.1038/s41388-025-03483-0↗
  2. Suppression of hypoxia-induced CAV1 autophagic degradation enhances nanoalbumin-paclitaxel transcytosis and improves therapeutic activity in pancreatic cancer. Last author DOI 10.1016/j.ejphar.2024.176431↗
  3. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis. Last author DOI 10.1186/s13046-020-01687-8↗
  4. TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT-GSK-3β-β-Catenin Si… Last author DOI 10.3389/fonc.2020.554787↗
  5. MiR-137 promotes anoikis through modulating the AKT signaling pathways in Pancreatic Cancer. Last author DOI 10.7150/jca.44037↗
  6. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway. Last author DOI 10.1038/s41419-019-1320-z↗
  7. MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12. Last author DOI 10.1186/s13046-019-1105-3↗
  8. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH. Last author DOI 10.1016/j.mcp.2018.06.003↗
  9. Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway. Last author DOI 10.3892/or.2018.6198↗
  10. Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway. Last author DOI 10.7150/thno.23259↗
  11. miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1. Co-author DOI 10.18632/oncotarget.14360↗
  12. TRIM37 promoted the growth and migration of the pancreatic cancer cells. Last author DOI 10.1007/s13277-015-4078-7↗
  13. Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells. Co-author DOI 10.1080/15548627.2016.1191722↗
  14. MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1. Last author DOI 10.1007/s13402-014-0200-x↗
  15. Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype. Last author DOI 10.18632/oncotarget.3089↗
  16. microRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy. Last author PMID 25550779↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chao Yu · 10 shared papers, 2014–2020 · strength 0.85
  2. Shiyu Chen · 5 shared papers, 2018–2020 · strength 0.58
  3. Zhiwei He · 5 shared papers, 2019–2020 · strength 0.56
  4. Jianxin Jiang · 7 shared papers, 2014–2019 · strength 0.47
  5. Kai Jiang · 1 shared paper, 2025 · strength 0.30
  6. Hui Liu · 1 shared paper, 2025 · strength 0.30
  7. Xingjun Guo · 4 shared papers, 2015–2019 · strength 0.29
  8. Xiangli Bai · 1 shared paper, 2024 · strength 0.28
  9. She Tian · 3 shared papers, 2016–2019 · strength 0.27
  10. Hao Zhang · 2 shared papers, 2015–2020 · strength 0.19
  11. Yaozhen Pan · 2 shared papers, 2018–2019 · strength 0.19
  12. Zili Chen · 2 shared papers, 2018 · strength 0.18
  13. Haitao Zhu · 2 shared papers, 2018 · strength 0.18
  14. Min Wang · 3 shared papers, 2014–2016 · strength 0.14
  15. Meiyuan Chen · 2 shared papers, 2015–2016 · strength 0.14
  16. Lin Li · 1 shared paper, 2020 · strength 0.13
  17. Li Lin · 1 shared paper, 2020 · strength 0.11
  18. Hong Zhang · 1 shared paper, 2019 · strength 0.10
  19. Jie Xiao · 2 shared papers, 2014–2015 · strength 0.10
  20. Xu Li · 2 shared papers, 2014–2016 · strength 0.09
  21. Qianfan Liu · 1 shared paper, 2018 · strength 0.08
  22. Liwen Chen · 1 shared paper, 2018 · strength 0.08
  23. Renyi Qin · 1 shared paper, 2016 · strength 0.05
  24. Qing Zhong · 1 shared paper, 2016 · strength 0.05
  25. Chengjian Shi · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.